Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Repolarization Syndrome: Define the Risk, Stratify the Coverage and Understand the Causes - Clinical and Genetic Study

NCT02847039 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT02847039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02847039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Repolarization Syndrome: Define the Risk, Stratify the Coverage and Understand the Causes - Clinical and Genetic Study
Lead sponsor
Nantes University Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2008
Completion date
December 31, 2021
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early repolarization syndrome